Patents Assigned to Resurgent Pharmaceuticals, Inc.
  • Patent number: 11083211
    Abstract: A non tobacco, cannabis based moist snuff composition is provided. The composition includes an herbal component primarily made up of cannabis leaves and/or stems and a casing component. Methods for producing a nontobacco cannabis based moist snuff composition are also provided. The method includes the steps of separating the leaves and stems from the cannabis plant, drying and curing them and mixing them with a casing component.
    Type: Grant
    Filed: April 10, 2017
    Date of Patent: August 10, 2021
    Assignee: RESURGENT PHARMACEUTICALS, INC.
    Inventors: Eric Greenbaum, Kyle Kingsley
  • Patent number: 10702565
    Abstract: A substantially pure fraction of at least one cannabinoid is added to smokable or smokeless tobacco products to reduce the harm associated with tobacco use. The harm to be reduced includes irritation and carcinogenicity of tobacco. In a preferred embodiment a whole plant cannabis extract is mixed directly with the tobacco during the curing or manufacturing process. For cigarette applications the cannabinoids may be inserted into a cigarette filter, and/or paper. In other embodiments the cannabinoids are purified.
    Type: Grant
    Filed: July 12, 2019
    Date of Patent: July 7, 2020
    Assignee: RESURGENT PHARMACEUTICALS, INC.
    Inventors: Eric Greenbaum, Kyle Kingsley
  • Patent number: 10369178
    Abstract: A substantially pure fraction of at least one cannabinoid is added to smokable or smokeless tobacco products to reduce the harm associated with tobacco use. The harm to be reduced includes irritation and carcinogenicity of tobacco. In a preferred embodiment a whole plant cannabis extract is mixed directly with the tobacco during the curing or manufacturing process. For cigarette applications the cannabinoids may be inserted into a cigarette filter, and/or paper. In other embodiments the cannabinoids are purified.
    Type: Grant
    Filed: March 6, 2017
    Date of Patent: August 6, 2019
    Assignee: Resurgent Pharmaceuticals, Inc.
    Inventors: Eric Greenbaum, Kyle Kingsley